1Desmond RA, Weiss HL, Arani RB, Soong SJ, Wood MJ, Fiddian PA. Clinical applications for change - point analysis of herpes zoster pain [ J ]. Journal of Pain and Symptom Management, 2002, 23 (6): 510-6.
2Donahue jG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster [ J ]. Arch Intern Med, 1995, 155 (15) : 1605-9.
3Scott FT, Leedham - Green ME, BarrettMuir WY, et al, A study of shingles and the development of postherpetic neuralgia in East London [J]. J Med Virol, 2003, 70 (Suppl 1 ) : S24 - 30.
4Bowsher D. Factors influencing the teatures of postherpetic neuralgia and outcome when treated with tricyclics [ J ]. Eur J Pain, 2003, 7 (1): 1-7.
5Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy [ J ]. Clin J Pain, 2002; 18 (6): 350-4.
6Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta - analysis of placebocontrolled trials [ J ]. Clin Infect Dis, 1996, 22 (2): 341-7.
7Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta- analysis [J]. Arch Intern Med, 1997, 157 (8): 909-12.
8Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults [J].Antimicrob Agents Chemother, 1995,39(7) : 1546 - 53.
9Tyring SK. Efficacy of famciclovir in the treatment of herpes zoster [ J]. Semin Dermatol, 1996, 15 (2Suppl 1): 27-31.
10Tyring SK, Beutner KR, Tucker BA, et al. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older [J]. ArchFamMed, 2000, 9 (9): 863-9.
